Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus

American Journal of Medicine

Volumn 105, Issue 5 A, 1998, Pages 17S-21S

  Bjorkman, David ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

COLITIS; CONFERENCE PAPER; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG INDUCED DISEASE; ENTERITIS; ESOPHAGUS DISEASE; ESOPHAGUS STRICTURE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0032476571     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00276-9     Document Type: Conference Paper

References (51)

1. Tolman KG. Hepatotoxicity of non-narcotic analgesics. Paper presented at: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Conference: Non-Narcotic Analgesics: Renal and GI Considerations; April 28-29, 1997; Bethesda, Md.
2. Kromann-Andersen H., Pedersen A. Reported adverse reactions to and consumption of nonsteroidal anti-inflammatory drugs in Denmark over a 17-year period. Danish Med Bull. 35:1988;187-192.
3. Lewis J.H., Zimmerman H.J. NSAID hepatotoxicity. Contemp OB/GYN. November:1996;81-101.
4. Jick H., Derby L.E., Garcia Rodriguez L.A., et al. Liver disease associated with diclofenac, naproxen, and piroxicam. Pharmacotherapy. 12:1992;207-212.
5. Carson J.L., Strom B.L., Duff A., et al. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. Arch Intern Med. 153:1993;1331-1336.
6. Manoukian A.V., Carson J.L. Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention. Drug Saf. 15:1996;64-71.
7. García Rodríguez L.A., Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 343:1994;769-772.
8. Fries J. Toward an understanding of NSAID-related adverse events the contribution of longitudinal data . Scand J Rheumatol Suppl. 102:(suppl):1996;3-8.
9. Fry S.W., Seeff L.B. Hepatotoxicity of analgesics and anti-inflammatory agents. Gastroenterol Clin North Am. 24:1995;875-905.
10. Boelsterli U.A., Zimmerman H.J., Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs molecular mechanisms and pathology . Crit Rev Toxicol. 25:1995;207-235.
11. Brass E.P. Hepatic toxicity of antirheumatic drugs. Cleve Clin J Med. 60:1993;466-472.
12. Zimmerman H.J. Update of hepatotoxicity due to classes of drugs in common clinical use non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents . Semin Liver Dis. 10:1990;322-338.
13. Zimmerman H.J., Lewis J.H. Drug-induced cholestasis. Med Toxicol. 2:1987;112-160.
14. Package insert for Cataflam/Voltaren (diclofenac). Physicians Desk Reference. Montvale, NJ: Medical Economics Co, 1998:1830-1834.
15. Zimmerman H.J. Effects of aspirin and acetaminophen on the liver. Arch Intern Med. 141:1981;333-342.
16. Walker A.M. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs. Arthritis Rheum. 40:1997;201-208.
17. García Rodriguez L.A., Williams R., Derby L.E., et al. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med. 154:1994;311-316.
18. Tarazi E.M., Harter J.G., Zimmerman H.J., et al. Sulindac-associated hepatic injury analysis of 91 cases reported to the Food and Drug Administration . Gastroenterology. 104:1993;569-574.
19. Purcell P., Henry D., Melville G. Diclofenac hepatitis. Gut. 32:1991;1381-1385.
20. Helfgott S.M., Sandberg-Cook J., Zakim D., Nestler J. Diclofenac-associated hepatotoxicity. JAMA. 264:1990;2660-2662.
21. Tolman K.G. Hepatotoxicity of antirheumatic drugs. J Rheumatol Suppl. 22:(suppl):1990;6-11.
22. Scully L.J., Clarke D., Barr R.J. Diclofenac induced hepatitis 3 cases with features of autoimmune chronic active hepatitis . Dig Dis Sci. 38:1993;744-751.
23. Banks A.T., Zimmerman H.J., Ishak K.G., Harter J.G. Diclofenac-associated hepatotoxicity analysis of 180 cases reported to the Food and Drug Administration as adverse reactions . Hepatology. 22:1995;820-827.
24. Davies N.M. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum. 38:1995;1311-1321.
25. Hirschowitz B.I. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Gastroenterologist. 2:1994;207-223.
26. Morris A.J., Madhok R., Sturrock R.D., et al. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet. 337:1991;520.
27. Kessler W.F., Shires G.T. III, Fahey T.J. III. Surgical complications of nonsteroidal antiinflammatory drug-induced small bowel ulceration. J Am Coll Surg. 185:1997;250-254.
28. Allison M.C., Howatson A.G., Torrance C.J., et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 327:1992;749-754.
29. Gibson G.R., Whitacre E.B., Ricotti C.A. Colitis induced by nonsteroidal anti-inflammatory drugs report of four cases and review of the literature . Arch Intern Med. 152:1992;625-632.
30. Kaufmann H.J., Taubin H.L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 107:1987;513-516.
31. Bjarnason I., Hayllar J., MacPherson A.J., Russell A.S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 104:1993;1832-1847.
32. Semble E.L., Wu W.C. Prostaglandins in the gut and their relationship to non-steroidal anti-inflammatory drugs. Baillieres Clin Rheumatol. 3:1989;247-269.
33. Langman M.J.S., Morgan L., Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed). 290:1985;347-349.
34. Lanas A.I., Arroyo M.T., Esteva F., et al. Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut. 39:1996;654-660.
35. Schafer A.I. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 35:1995;209-219.
36. Lanas A., Sekar M.C., Hirschowitz B.I. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology. 103:1992;862-869.
37. Wilcox C.M., Alexander L.N., Cotsonis G.A., Clark W.S. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci. 42:1997;990-997.
38. Holt S., Rigoglioso V., Sidhu M., et al. Nonsteroidal antiinflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci. 38:1993;1619-1623.
39. Lanas A., Serrano P., Bajador E., et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 112:1997;683-689.
40. Lang J., Price A.B., Levi A.J., et al. Diaphragm disease pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs . J Clin Pathol. 41:1988;516-526.
41. Hooker G.D., Gregor J.C., Ponich T.P., McLarty T.D. Diaphragm-like strictures of the right colon induced by indomethacin suppositories evidence of a systemic effect . Gastrointest Endosc. 44:1996;199-202.
42. McGonigal A., Moffat D.F., Lindop G.B., Gilchrist W.J. Nonsteroidal anti-inflammatory drug associated diaphragm disease. Postgrad Med J. 73:1997;505-506.
43. Gargot D., Chaussade S., d'Alteroche L., et al. Nonsteroidal anti-inflammatory drug-induced colonic strictures two cases and literature review . Am J Gastroenterol. 90:1995;2035-2038.
44. Speed C.A., Bramble M.G., Corbett W.A., Haslock I. Non-steroidal anti-inflammatory induced diaphragm disease of the small intestine complexities of diagnosis and management . Br J Rheumatol. 33:1994;778-780.
45. Bjarnason I., Price A.B., Zanelli G., et al. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology. 94:1988;1070-1074.
46. Whitcomb D.C., Martin S.P., Trellis D.R., et al. Diaphragmlike stricture and ulcer of the colon during diclofenac treatment. Arch Intern Med. 152:1992;2341-2343.
47. Huber T., Ruchti C., Halter F. Nonsteroidal antiinflammatory drug-induced colonic strictures a case report . Gastroenterology. 100:1991;1119-1122.
48. Halter F., Weber B., Huber T., et al. Diaphragm disease of the ascending colon association with sustained-release diclofenac . J Clin Gastroenterol. 16:1993;74-80.
49. Heller S.R., Fellows I.W., Ogilvie A.L., Atkinson M. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. Br Med J. 285:1982;167-168.
50. Wilkins W.E., Ridley M.G., Pozniak A.L. Benign stricture of the oesophagus role of non-steroidal anti-inflammatory drugs . Gut. 25:1984;478-480.
51. Taha A.S., Dahill S., Nakshabendi I., et al. Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs. J Clin Pathol. 47:1994;705-708.